| [18F] FDG PET signal correlates with markers of neo-angiogenesis in patients with fibrotic interstitial lung disease who underwent lung biopsy: Implication for the use of PET … JC Porter, B Ganeshan, T Win, F Fraioli, S Khan, M Rodriguez-Justo, ... | | 2022 |
| 18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials T Win, T Lambrou, BF Hutton, I Kayani, NJ Screaton, JC Porter, TM Maher, ... European journal of nuclear medicine and molecular imaging 39, 521-528, 2012 | 65 | 2012 |
| 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study BMJ Guardela, J Sun, T Zhang, B Xu, J Balnis, Y Huang, SF Ma, ... EBioMedicine 69, 2021 | 12 | 2021 |
| 50-Gene Risk Profiles in Peripheral Blood Predict COVID-19 Severity BM Juan-Guardela, J Sun, T Zhang, B Xu, Y Huang, SF Ma, ... TP105. TP105 BASIC MECHANISMS OF LUNG INFECTIONS: FROM SARS-COV-2 TO …, 2021 | | 2021 |
| A 52-Gene Signature In Peripheral Blood Identifies An Ipf Subphenotype With Rapid Disease Progression And Poor Disease Outcomes J Herazo-Maya, J Sun, SR Duncan, A Prasse, I Noth, J Villabla-Nunez, ... A94. NEW INSIGHTS IN IPF, A2609-A2609, 2016 | | 2016 |
| A clinical approach to diffuse parenchymal lung disease TM Maher Immunology and Allergy Clinics 32 (4), 453-472, 2012 | 25 | 2012 |
| A clinical short‐cut to identifying short telomeres in idiopathic pulmonary fibrosis? TM Maher Respirology 27 (11), 916-917, 2022 | | 2022 |
| A Comparison Of Current Guideline And Multidisciplinary-Based Working Diagnosis Algorithms In The Diagnosis Of Idiopathic Pulmonary Fibrosis EP Judge, J Jacob, TM Maher, EA Renzoni, M Kokosi, AU Wells A42. NEW DEVELOPMENTS IN ILD RESEARCH, A1559-A1559, 2017 | 1 | 2017 |
| A comparison of two scoring methods for the King's brief interstitial lung disease questionnaire A Sinha, S Bajwah, H Gosker, R Siegert, D Creamer, G Larkin, T Maher, ... European Respiratory Journal 46 (suppl 59), 2015 | 1 | 2015 |
| A comparison of two scoring methods for the King's sarcoidosis questionnaire A Sinha, S Bajwah, H Gosker, R Siegert, D Creamer, G Larkin, T Maher, ... European Respiratory Journal 46 (suppl 59), 2015 | 3 | 2015 |
| A cost-effectiveness analysis of nintedanib in idiopathic pulmonary fibrosis in the UK C Rinciog, M Watkins, S Chang, TM Maher, C LeReun, D Esser, ... Pharmacoeconomics 35, 479-491, 2017 | 40 | 2017 |
| A Genome-Wide Association Study of the Age-of-Onset of Idiopathic Pulmonary Fibrosis Using Time-to-Event Analysis Methods L Kraven, R Allen, A Taylor, E Oballa, A Kang'ombe, N Kaminski, M Whyte, ... HUMAN HEREDITY 84 (4-5), 214-214, 2020 | | 2020 |
| A Global Evaluation of Agreement on the Decision to Perform Surgical Lung Biopsy Between Pulmonologists in the Setting of Diffuse Lung Disease SLF Walsh, TM Maher, MRJ Kolb, V Poletti, R Nusser, L Richeldi, ... A23. ILD: DIAGNOSIS, A1099-A1099, 2018 | | 2018 |
| A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results from an international survey M Kreuter, M Polke, S Walsh, HR Collard, N Chaudhuri, S Avdeev, J Behr, ... European Respiratory Journal 52 (suppl 62), 2018 | 9 | 2018 |
| A lesson in plasticity: a 74-year-old man with plastic bronchitis A Shah, J Donovan, P Marino, PL Shah, A Devaraj, K Wechalekar, ... Thorax 72 (11), 1055-1057, 2017 | 6 | 2017 |
| A modified blood cell GAP (cGAP) to prognosticate outcomes in IPF M Kreuter, JS Lee, A Tzouvelekis, JM Oldham, PL Molyneaux, D Weycker, ... European Respiratory Journal 60, 2022 | | 2022 |
| A MUC5B PROMOTER POLYMORPHISM AND PULMONARY FIBROSIS IN SSc C Stock, H Sato, C Fonseca, GE Lindahl, TM Maher, AU Wells, CP Denton, ... RHEUMATOLOGY 51, 30-30, 2012 | | 2012 |
| A Mucin 5B (MUC5B) Promoter Polymorphism In Sarcoidosis C Stock, H Sato, G Lindahl, T Maher, A Wells, E Renzoni A34. NEW INSIGHTS INTO SARCOIDOSIS, A1351-A1351, 2012 | | 2012 |
| A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial SS Birring, MS Wijsenbeek, S Agrawal, JWK van den Berg, H Stone, ... The Lancet Respiratory Medicine 5 (10), 806-815, 2017 | 108 | 2017 |
| A phase 2b randomized trial to evaluate LYT-100 in patients with idiopathic pulmonary fibrosis (IPF) P Ford, V Cottin, K Flaherty, T Maher, P Noble, M Wijsenbeek, M Chen, ... European Respiratory Journal 60 (suppl 66), 2022 | | 2022 |
Athol U WellsProfessor of Respiratory Medicine, Imperial College,在 rbht.nhs.uk 的电子邮件经过验证
